| LINE ITEM (USD / %) | FY 2025
FILED 2025-08-30 | FY 2024
FILED 2024-08-31 | FY 2023
FILED 2023-08-26 |
|---|---|---|---|
| Revenue (Total Sales) | $1.45B | $1.33B | $1.24B |
| YoY Revenue Growth % | +9.0% | +7.1% | — |
| Gross Profit | $525.7M | $511.6M | — |
| Gross Margin % | 36.2% | 38.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $156.9M | $206.5M | $204.9M |
| Operating Margin % | 10.8% | 15.5% | 16.5% |
| Net Income (GAAP) | $103.6M | $139.3M | $133.6M |
| EBITDA (Normalized) | $173.3M | $211.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $178.5M | $215.7M | $171.1M |
| Capital Expenditures (CapEx) | $20.5M | $5.7M | — |
| Free Cash Flow (FCF) | $157.9M | $210.0M | $171.1M |
| FCF Margin % | 10.9% | 15.8% | 13.8% |
| Return on Invested Capital (ROIC %) | 6.4% | 8.1% | — |
| Cash & Short-Term Equivalents | $194.1M | $121.8M | — |
| Total Debt (Short + Long Term) | $396.7M | $348.0M | — |
| Total Stockholders' Equity | $1.73B | $1.78B | — |